Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
eNq1mFFv2jAQx9/5FFHeSQgdo0yBamPthtRqjBZt2ktlkqOYuXZ6toHu088hdKOTo64GP8Z2/nf23f18cnq2uWfBClBSwfthErXCAHgmcsrv+uH05qJ5Gp4NGumSrMjesm7UipJ2GGSMSNkPy9loBoTL6PvV5Ucw/wOGg0aQitkSMvVsnVaURZ+JXFyRolwTpCtB8+Ae1ELk/bDQajsapFKh8WKwFvhTFiSDNN6N7M8ub9/sj6dxKfYfqloCXhJ+ZxUF7qSZaUTgakgU3Al8rPH3xEmbyglIoTGDMVGLMYoVzSG3mpgTJsHJyHydXwOuGKjSiFU8Xmb30kmcLMlmAg8ju9PvzexQbVSz1Uy63U47STrdXnLadTKFe0dlj4LZRJzdJt12u9c6iYHHjHClpWNoxgIVYZ6CQuXweV55soPw8GLwcyoLRh6jpSxcj4ogMdOApvr9baTcwQ0aHjFzZv/oc81Y/EqvpztaePK4hNFQaK5qoHExcT2IoeAKNvURdeOc2uxykYI8nuwvwe2MH+sZo5kr0QxzNEg1nYzqgXZEFnwgEqboDwbfKM/FWh4fMvtB9eR9seWkVbTAPLlt907fJp2Ocw39MBlUc7+caxQFxAY/VB5ClRGfi0N5YpLSLvWUksfKxm2TIzLCoKbNaTqSxaThU1fmLdH9FVE1YRX9dH7jmh1fNeDj9fbTKk3z/p+4umHXB8tNLtY6/vrMrgrcSwOs0Q6OhVKFfBfH6/U6WhDZlKZcIJrjsbm+d5P66769XNdV+1Kx0ZPrs+rSe12AXAvtpQv90CZ19/+uGbbaUKjhgFhUTPZGztH58WH8t0P15vb4GTz8mdl2k0RRwX21OXpmVTwM/yau/AINIL7M57TmNaQ2L9O4eokZNNK4fIUZNH4D613jPw==
vmSYNMdDaMzQ9Jwv
